FT商学院

Psychedelics: cleansing the doors of perception — and opening VC wallets

Venture capitalists have put $236mn into mind-expanding treatment research in the 12 months to July

Denizens of Silicon Valley have long hailed microdoses of psychedelic drugs as a means of unlocking creativity. Where tech leads, the US follows. NFL star Aaron Rodgers credits the South American drug ayahuasca with improving his wellbeing and his playing. Mind-expanding treatments are a burgeoning area of medical research and venture capital investment.

Psychedelics inspired writer Aldous Huxley, psychologist Timothy Leary and some garish album cover art in the seventies. They may be useful as medicines for the same reason they appeal to artists. The drugs supposedly induce “neuroplasticity” — a rewiring of thought processes to reduce negativity and increase connectedness.

Critics counter that psychedelics can cause irreparable damage. These drugs include LSD, psilocybin (magic mushrooms), ayahuasca and ketamine.

您已阅读39%(823字),剩余61%(1275字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×